L-Epicatechin; 2-(3,4-Dihydroxyphenyl)chroman-3,5,7-triol; DL-Catechin; (+/-)-Catechin; 2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol; Catechin (hydrate); 2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol; epi-Catechol; (+/-)-Epicatechin; (+)-Catechin;Cianidanol;Catechuic acid; (-)-3,5,7,3',4'-PENTAHYDROXYFLAVAN; l-Epicatechol; DL-Catechin; Racemic catechin; dl-Catechin; dl-Catechol; rac-Catechin; (2R,3R)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol; Epicatechol, (-)-; 2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-,(2R,3S)-rel-; 2-(3,4-Dihydroxyphenyl)chromane-3,5,7-triol; (2R,3R)-(-)-Epicatechin; catechins; Catachin; MFCD00075648; NSC 81161; NCGC00015215-02; EINECS 241-357-4; NSC 81162; 2-(3,4-Dihydroxyphenyl)-3,5,7-chromanetriol #; Prestwick3_000817; Epicatechin, (+/-)-; (-)-(2R:3R)-5,7,3',4'-Tetrahydroxyflavan-3-ol; (-)-CATECHINHYDRATE; SCHEMBL19411; BSPBio_000713; BPBio1_000785; CHEMBL206452; SCHEMBL10001669; DTXSID10859304; 2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R,3R)-; HMS1664H16; 2H-1-Benzopyran-3,5,7-triol,2-(3,4-dihydroxyphenyl)-3,4-dihydro-; BDBM50479045; MFCD00066757; AKOS016009549; cis-(1)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol; (+)-3,3',4',5,7-Flavanpentol; MCULE-4219942050; NCGC00015215-03; NCGC00015215-04; NCGC00095270-01; NCGC00095270-02; AK-77017; AK105372; AK111290; BS-15212; SC-65140; SC-86438; DB-017858; DB-050100; AB00513926; FT-0604384; FT-0613995; FT-0614024; FT-0636422; (-)-cis-3,3',4',5,7-Pentahydroxyflavane; (?)-cis-3,3',4',5,7-Pentahydroxyflavane; C17590; BRD-A61899133-002-02-2; Q51617472; 714E3A52-14F7-4C41-BF5D-1DAA0C81FCC5